File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma

TitleRandomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
Authors
Abou-Alfa, GKPuig, ODaniele, BKudo, MMerle, PPark, JWRoss, PPeron, JMEbert, OChan, SPoon, RTPColombo, MOkusaka, TRyoo, BYMinguez, BTanaka, TOhtomo, TUkrainskyj, SBoisserie, FRutman, OChen, YCXu, CShochat, EJukofsky, LReis, BChen, GDi Laurenzio, LLee, RYen, CJ
KeywordsCD16
Codrituzumab
Glypican-3
Hepatocellular carcinoma
Issue Date2016
Citation
Journal of Hepatology, 2016, v. 65 n. 2, p. 289-295 How to Cite?
DOI: http://dx.doi.org/10.1016/j.jhep.2016.04.004
Persistent Identifierhttp://hdl.handle.net/10722/237049
ISI Accession Number ID
WOS:000380516900012

 

DC FieldValueLanguage
dc.contributor.authorAbou-Alfa, GK-
dc.contributor.authorPuig, O-
dc.contributor.authorDaniele, B-
dc.contributor.authorKudo, M-
dc.contributor.authorMerle, P-
dc.contributor.authorPark, JW-
dc.contributor.authorRoss, P-
dc.contributor.authorPeron, JM-
dc.contributor.authorEbert, O-
dc.contributor.authorChan, S-
dc.contributor.authorPoon, RTP-
dc.contributor.authorColombo, M-
dc.contributor.authorOkusaka, T-
dc.contributor.authorRyoo, BY-
dc.contributor.authorMinguez, B-
dc.contributor.authorTanaka, T-
dc.contributor.authorOhtomo, T-
dc.contributor.authorUkrainskyj, S-
dc.contributor.authorBoisserie, F-
dc.contributor.authorRutman, O-
dc.contributor.authorChen, YC-
dc.contributor.authorXu, C-
dc.contributor.authorShochat, E-
dc.contributor.authorJukofsky, L-
dc.contributor.authorReis, B-
dc.contributor.authorChen, G-
dc.contributor.authorDi Laurenzio, L-
dc.contributor.authorLee, R-
dc.contributor.authorYen, CJ-
dc.date.accessioned2016-12-20T06:15:32Z-
dc.date.available2016-12-20T06:15:32Z-
dc.date.issued2016-
dc.identifier.citationJournal of Hepatology, 2016, v. 65 n. 2, p. 289-295-
dc.identifier.urihttp://hdl.handle.net/10722/237049-
dc.languageeng-
dc.relation.ispartofJournal of Hepatology-
dc.subjectCD16-
dc.subjectCodrituzumab-
dc.subjectGlypican-3-
dc.subjectHepatocellular carcinoma-
dc.titleRandomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma-
dc.typeArticle-
dc.identifier.emailPoon, RTP: poontp@hku.hk-
dc.identifier.authorityPoon, RTP=rp00446-
dc.identifier.doi10.1016/j.jhep.2016.04.004-
dc.identifier.scopuseid_2-s2.0-84973573738-
dc.identifier.hkuros270735-
dc.identifier.volume65-
dc.identifier.issue2-
dc.identifier.spage289-
dc.identifier.epage295-
dc.identifier.isiWOS:000380516900012-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats